Francesca Montagnolo

Bari, 70121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Exhaled acetylcholine in breath condensate as a non-invasive biomarker of asthma control: Insights from patients treated with extrafine single-inhaler triple therapy.

Exhaled acetylcholine in breath condensate as a non-invasive biomarker of asthma control: Insights from patients treated with extrafine single-inhaler triple therapy.

Journal: Respiratory medicine

Published: May 26, 2026

Steady Quiet Asthma Without Biologics: One-Year Outcomes of Single-Inhaler Triple Therapy for Severe Asthma with Small Airway Dysfunction.

Steady Quiet Asthma Without Biologics: One-Year Outcomes of Single-Inhaler Triple Therapy for Severe Asthma with Small Airway Dysfunction.

Journal: Journal of clinical medicine

Published: July 05, 2025

The impact of tezepelumab therapy on perceived asthma triggers: a multicenter real-life study.

The impact of tezepelumab therapy on perceived asthma triggers: a multicenter real-life study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: April 21, 2025

Short-term Tezepelumab effectiveness in patients with severe asthma: a multicenter study.

Short-term Tezepelumab effectiveness in patients with severe asthma: a multicenter study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: September 26, 2024

Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study.

Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study.

Journal: Journal of clinical medicine

Published: September 09, 2024

Successful Benralizumab treatment in acute near-fatal asthma with ECMO support: a case report.

Successful Benralizumab treatment in acute near-fatal asthma with ECMO support: a case report.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: July 01, 2024

Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.

Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.

Journal: Journal of breath research

Published: May 23, 2024

Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the "Silent Zone" to Achieving "Quiet Asthma".

Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the "Silent Zone" to Achieving "Quiet Asthma".

Journal: Journal of clinical medicine

Published: March 01, 2024

Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission.

Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission.

Journal: Frontiers in immunology

Published: November 23, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026